Compare Arbitrum (ARB) vs Immunefi (IMU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arbitrum vs Immunefi — how do they compare? Arbitrum trades at Rp1,329 (market cap Rp8,77T, Rp666,43M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Arbitrum is far larger — about 324454.3× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Arbitrum's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 63 Days and Immunefi for 5 Days on average.
| ARB | IMU | |
|---|---|---|
Market Cap | Rp8,77T | Rp27,03M |
Volume (24h) | Rp666,43M | Rp39,91M |
Circulating Supply | 6,6B ARB | 873,4M / 10B IMU (9%) |
Typical Hold Time | 63 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arbitrum (ARB) is currently trading at Rp1,320 with a market cap of Rp8.83T, showing bearish technical signals across most indicators. The token faces strong selling pressure with 18 sell signals versus only 1 buy signal. Recent news includes Pheasant Network's $2M funding round with Ethereum Foundation support, which could boost AI-powered cross-chain capabilities within the Arbitrum ecosystem.
Overall outlook remains cautious with bearish momentum dominating. Key opportunities include ecosystem growth from AI integration projects, while major risks involve continued technical selling pressure and crypto market volatility. Investors should monitor support at Rp1,272 and resistance at Rp1,346 for potential breakout directions.
IMU token shows limited market activity with a modest market cap of Rp27.03M and only 9% circulating supply. The token exhibits low trading volume and minimal network activity, with a short average hold time of 5 days indicating speculative trading patterns. Recent coverage appears to confuse this cryptocurrency with a corporate entity, creating market confusion.
Outlook remains cautious due to extremely low liquidity and market confusion with traditional equity. Key risk is entity misidentification impacting proper valuation. Opportunity exists if protocol utility develops, but current fundamentals are weak with minimal ecosystem activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arbitrum
Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.
Read more on ARB →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
